Table 1.
Characteristics of study population at baseline (N=76).
| Characteristic | N | % |
|---|---|---|
| Age | ||
| <50 years | 13 | 17% |
| 50–54 years | 11 | 14% |
| 55–59 years | 10 | 13% |
| 60–64 years | 14 | 18% |
| 65–69 years | 12 | 16% |
| 70–74 years | 9 | 12% |
| 75–79 years | 5 | 7% |
| ≥ 75 years | 2 | 3% |
| Male | 51 | 67% |
| White | 68 | 88% |
| Body mass index category | ||
| Normal Weight (18.5 kg/m2 to <25 kg/m2) | 10 | 13% |
| Overweight (25 kg/m2 to <30 kg/m2) | 31 | 41% |
| Obese (≥30 kg/m2) | 35 | 46% |
| History of: | ||
| Myocardial infarction | 45 | 59% |
| Coronary bypass surgery | 4 | 5% |
| Stent | 65 | 86% |
| Chronic obstructive pulmonary disease | 13 | 17% |
| Type 2 diabetes mellitus | 17 | 22% |
| Hypertension | 45 | 59% |
| Smoking | ||
| Never | 40 | 53% |
| Former | 36 | 47% |
| Daily Medication use at 1st Visit: | ||
| Angiotensin Receptor Blocker | 10 | 13% |
| Beta-blocker | 66 | 87% |
| Angiotensin Converting Enzyme Inhibitor | 50 | 66% |
| Calcium channel blocker | 7 | 9% |
| Digitalis | 1 | 1% |
| Diuretic | 20 | 26% |
| Statin | 73 | 96% |